BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25649416)

  • 1. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.
    Stahl P; Seeschaaf C; Lebok P; Kutup A; Bockhorn M; Izbicki JR; Bokemeyer C; Simon R; Sauter G; Marx AH
    BMC Gastroenterol; 2015 Feb; 15():7. PubMed ID: 25649416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
    Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
    Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
    Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.
    Seiler R; Thalmann GN; Rotzer D; Perren A; Fleischmann A
    Mod Pathol; 2014 Jan; 27(1):87-95. PubMed ID: 23887292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
    Singhi AD; Cimino-Mathews A; Jenkins RB; Lan F; Fink SR; Nassar H; Vang R; Fetting JH; Hicks J; Sukumar S; De Marzo AM; Argani P
    Mod Pathol; 2012 Mar; 25(3):378-87. PubMed ID: 22056952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
    Nishida Y; Kuwata T; Nitta H; Dennis E; Aizawa M; Kinoshita T; Ohtsu A; Ochiai A
    Gastric Cancer; 2015 Jul; 18(3):458-66. PubMed ID: 24917219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization.
    Tajiri R; Ooi A; Fujimura T; Dobashi Y; Oyama T; Nakamura R; Ikeda H
    Hum Pathol; 2014 Apr; 45(4):725-34. PubMed ID: 24491355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
    Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
    Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.
    Tsapralis D; Panayiotides I; Peros G; Liakakos T; Karamitopoulou E
    World J Gastroenterol; 2012 Jan; 18(2):150-5. PubMed ID: 22253521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 gene amplification is highly homogeneous in breast cancer.
    Burandt E; Grünert M; Lebeau A; Choschzick M; Quaas A; Jänicke F; Müller V; Scholz U; Bokemeyer C; Petersen C; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Wilczak W
    Breast Cancer; 2016 Jan; 23(1):111-119. PubMed ID: 24862872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
    Moelans CB; Milne AN; Morsink FH; Offerhaus GJ; van Diest PJ
    Cell Oncol (Dordr); 2011 Apr; 34(2):89-95. PubMed ID: 21394646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
    Fusco N; Rocco EG; Del Conte C; Pellegrini C; Bulfamante G; Di Nuovo F; Romagnoli S; Bosari S
    Mod Pathol; 2013 Jun; 26(6):816-24. PubMed ID: 23348899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
    Bizari L; Borim AA; Leite KR; Gonçalves Fde T; Cury PM; Tajara EH; Silva AE
    Cancer Genet Cytogenet; 2006 Feb; 165(1):41-50. PubMed ID: 16490596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification in ductal carcinoma in situ of the breast.
    Burkhardt L; Grob TJ; Hermann I; Burandt E; Choschzick M; Jänicke F; Müller V; Bokemeyer C; Simon R; Sauter G; Wilczak W; Lebeau A
    Breast Cancer Res Treat; 2010 Oct; 123(3):757-65. PubMed ID: 20033484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry.
    Tabarestani S; Ghaderian SM; Rezvani H
    Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2 amplification is highly homogenous in gastric cancer.
    Marx AH; Tharun L; Muth J; Dancau AM; Simon R; Yekebas E; Kaifi JT; Mirlacher M; Brümmendorf TH; Bokemeyer C; Izbicki JR; Sauter G
    Hum Pathol; 2009 Jun; 40(6):769-77. PubMed ID: 19269014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.